MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
73
Beneficiaries
—
Total drug cost
$2.8M
Distinct drugs
4
Brand share
100.0%
Top prescribed drugs
Berotralstat Hydrochloride22 claims
Lanadelumab-Flyo21 claims
Dupilumab15 claims
C1 Esterase Inhibitor15 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
CROSS-REFERENCE